These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22929437)

  • 21. The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.
    Deane AM; Chapman MJ; Fraser RJ; Burgstad CM; Besanko LK; Horowitz M
    Crit Care; 2009; 13(3):R67. PubMed ID: 19439067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia.
    Green CJ; Henriksen TI; Pedersen BK; Solomon TP
    PLoS One; 2012; 7(8):e44284. PubMed ID: 22937169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.
    Smushkin G; Sathananthan M; Sathananthan A; Dalla Man C; Micheletto F; Zinsmeister AR; Cobelli C; Vella A
    Diabetes; 2012 May; 61(5):1082-9. PubMed ID: 22461567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions.
    Fukuda S; Nakagawa S; Tatsumi R; Morofuji Y; Takeshita T; Hayashi K; Tanaka K; Matsuo T; Niwa M
    J Mol Neurosci; 2016 Jun; 59(2):211-9. PubMed ID: 26659380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine pre-exposure reduces stroke-induced glucose transporter-1 activity at the blood-brain barrier in mice.
    Shah KK; Boreddy PR; Abbruscato TJ
    Fluids Barriers CNS; 2015 Apr; 12():10. PubMed ID: 25925411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
    Knauf C; Cani PD; Perrin C; Iglesias MA; Maury JF; Bernard E; Benhamed F; Grémeaux T; Drucker DJ; Kahn CR; Girard J; Tanti JF; Delzenne NM; Postic C; Burcelin R
    J Clin Invest; 2005 Dec; 115(12):3554-63. PubMed ID: 16322793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
    Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
    Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?].
    García-Casares N; García-Arnés JA; Gómez-Huelgas R; Valdivielso-Felices P; García-Arias C; González-Santos P
    Rev Neurol; 2014 Dec; 59(11):517-24. PubMed ID: 25418147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.
    Moriya R; Shirakura T; Ito J; Mashiko S; Seo T
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1358-65. PubMed ID: 19808907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycemia potentiates the slowing of gastric emptying induced by exogenous GLP-1.
    Plummer MP; Jones KL; Cousins CE; Trahair LG; Meier JJ; Chapman MJ; Horowitz M; Deane AM
    Diabetes Care; 2015 Jun; 38(6):1123-9. PubMed ID: 25784665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of a clinically relevant stroke model: glucose hypermetabolism revisited.
    Arnberg F; Grafström J; Lundberg J; Nikkhou-Aski S; Little P; Damberg P; Mitsios N; Mulder J; Lu L; Söderman M; Stone-Elander S; Holmin S
    Stroke; 2015 Mar; 46(3):835-42. PubMed ID: 25657187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.
    Gutzwiller JP; Drewe J; Göke B; Schmidt H; Rohrer B; Lareida J; Beglinger C
    Am J Physiol; 1999 May; 276(5):R1541-4. PubMed ID: 10233049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
    Liu W; Zhuo P; Li L; Jin H; Lin B; Zhang Y; Liang S; Wu J; Huang J; Wang Z; Lin R; Chen L; Tao J
    Free Radic Biol Med; 2017 Nov; 112():174-190. PubMed ID: 28756309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats.
    Jessen L; Smith EP; Ulrich-Lai Y; Herman JP; Seeley RJ; Sandoval D; D'Alessio D
    Endocrinology; 2017 Jul; 158(7):2124-2133. PubMed ID: 28430981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes.
    Meier JJ; Weyhe D; Michaely M; Senkal M; Zumtobel V; Nauck MA; Holst JJ; Schmidt WE; Gallwitz B
    Crit Care Med; 2004 Mar; 32(3):848-51. PubMed ID: 15090972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion.
    Hansen M; Scheltema MJ; Sonne DP; Hansen JS; Sperling M; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2016 Jun; 18(6):571-80. PubMed ID: 26888164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose.
    Chang AM; Jakobsen G; Sturis J; Smith MJ; Bloem CJ; An B; Galecki A; Halter JB
    Diabetes; 2003 Jul; 52(7):1786-91. PubMed ID: 12829647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.